LTC2007/52.7
UNIVERSITY OF GLASGOW
Learning and Teaching Committee – Wednesday 28 May 2008
Faculty of Medicine Planning & Budgeting – 2008/09 - Update January
2008
Dr Vince Bissell
May 2008
1. Introduction
In line with the University’s Strategic Plan 2006-10, the Faculty’s top-level aims for this
period are:






To maintain and strengthen the University’s position in the UK and international league tables;
we have recently moved up significantly from 75th in the world biomedical ranking to 60th
position;
To strengthen our position as an international leader in biomedical research and for this to be
recognised in the results of the 2008 Research Assessment Exercise;
To be renowned internationally for our innovative medical, dental and nursing education, that is
shaped by the diversity and richness of our research environment;
To make a positive impact on the health of the Scottish population through translational,
clinical, and public health research, and by training an increasing number of Scotland’s doctors,
dentists and nurses;
To strengthen and expand our postgraduate provision, with an emphasis on increasing overseas
recruitment;
To be a place which retains and attracts the very best staff.
Specifically, for 2008-09 and beyond, we have the following objectives:

Moving forward from RAE2008, to ensure that we are well-placed for our international
excellence to be recognised in future metrics-based assessments, to obtain the best research
profile and the best financial return for the University;

To continue to build upon our investments in our three priority research areas of cardiovascular,
cancer, and infection, immunity & inflammation, by delivering world-class research that
translates into clinical benefits. These priority areas require continued investment to remain
internationally competitive;

To continue to strengthen and consolidate, where possible, our strengths in other research areas,
for example in neuroscience and public health;

To strive to achieve a balanced research portfolio in funding terms in order to achieve an
increasingly higher proportion of full economic costs and to ensure research sustainability;

To maximise our undergraduate student numbers in medicine (through our successful bid for St
Andrews students for their clinical training, following the Calman Report), Nursing and
Dentistry;
18/1/08
1
LTC2007/52.7

To increase our postgraduate student numbers, and particularly international postgraduate
student numbers, through our new and expanded MSc taught courses and also by attracting the
most able graduate research students;

To ensure that the Faculty is fully engaged in the planning of relevant NHS developments in
Glasgow, notably the establishment of the South Glasgow Hospital and the reconfiguration of
the Queen Elizabeth Building (QEB) at Glasgow Royal Infirmary, in order to optimise the
effect on the goals of the Medical Faculty.
Brief summary of intentions for 2008/09.
At the highest level, the Faculty of Medicine’s strategy must be to sustain and invest in
research excellence in our three priority research areas; a wider range of areas for our clinical
research activity ( which sustain >60% of Scottish commercial trial leadership); and the
necessary broad base for our educational programmes, some of which face significant planned
expansion.
The biomedical territory has achieved a significant increase in position (from 75th to 60th) in
the THES league tables this year, and this is in contrast to other subject groups within the
University. Therefore, if the University is to achieve its goal of being within the top 50
institutions, it essential that the biomedical territory does not simply maintain its position, but
continues to improve against its competitors. On the research side, this will require us to focus
strategically, and to invest substantially in our three key priority areas, to ensure that these
areas remain internationally competitive, especially as competitor institutions are investing
heavily in these areas.
There has already been substantial investment in research facilities and, although there is
ongoing fundraising for Beatson Phases 2 & 3, the predominant future area for capital
investment will be for clinical academic facilities on the two major acute hospital sites (GRI
2008-10) (SGH 2011-14) to match the unprecedented reconfiguration of Glasgow’s hospitals
by NHS GGC. There is ongoing liaison with senior management within NHS GGC across the
interface of the two institutions and the potential for developing an academic health centre
will be explored. In addition, it is essential that the Gilmorehill campus maintains its strengths
in basic and translational research and this requires essential investment in magnetic
resonance imaging (MRI) facilities this year. It is likely that the BHF will fund up to £1.5M
towards this development provided there will be matching funding from the University for the
necessary infrastructure.
UG Students
o
Professor Jill Morrison and her team will continue to plan for the additional UG
medical students coming from St Andrews (estimated to be at least 25 -30 annually
from 2010 onwards ).
PG Students
o
Several new courses have been developed and these will continue to develop and
expand PGT numbers.
o Dentistry will launch new PGT courses aimed at overseas students
o Existing PGT courses will be expanded where possible.
o The Faculty will aim to expand PGR students in its new research facilities –
BHFGCRC (including a new application for 8 posts (4 clinical & 4 non-clinical) for 5
years), GBRC, Leukaemia Research Centre and the Beatson Institute,
18/1/08
2
LTC2007/52.7
o
We will continue the scheme of offering 30 PGR and PGT overseas students a
discount equivalent to the home fee if they come to Glasgow.
Research Contribution
o
We plan to increase the number of Wyeth applications that have full FEC funding.
New arrangements are being put in place to have a clinical lead for Wyeth who will
work with R&E and academics interesting in applying for Wyeth funding. In
addition, we propose to employ a new Business Development Manager within the
Faculty to specifically increase research income from sources that meet or exceed
FEC (see attached appendix). This post has not been included in the attached I&E,
but the Faculty would like permission to move forward with this approach as
recommended by the Vice-Principal (Research & Enterprise).
Research Strategy
o
To sustain and strengthen our international competitiveness predominantly in our
three priority areas - cardiovascular, cancer, immunology & inflammation research.
In particular, we would like the ability to invest further in the areas of cardiovascular
and immunology & inflammation by being able to respond to opportunities that arise
during the financial year to recruit research stars in these areas. We ask that an
allocation of £250k per area be made available for this possibility. In any one year it
cannot be predicted that this will be spent but when opportunities arise there is a
serious need to be able to respond to these quickly. Such opportunities are not created
simply by advertising in a planned way and so specific new posts have not been
included in the budget. Any investment would, of course, be backed by business
plans incorporating new income and redeployment of existing posts.
o
To focus appropriate basic and translational research on the Gilmorehill Campus
where practicable (BHFGCRC & GBRC). As mentioned above, we urgently require
MRI facilities on the Gilmorehill site and we are hopeful that the BHF may fund the
full cost of an MRI scanner to be located in the BHFGCRC. The University will be
required to meet the cost of the refurbishment required to accommodate the scanner.
o
To progress the plans for reconfiguration of hospital site-based research with the
focus on clinical research, including clinical trials, and near to patient laboratory
research (GRI and SGH).
o
To establish the Glasgow Centre for Cancer Research across Gartnavel and Garscube
and fostering closer working relationships between the component units.
o
To strive to achieve a balanced research portfolio in funding terms in order to achieve
an increasingly higher proportion of full economic costs and to ensure research
sustainability;
Staff Strategy
o
o
To strive to ensure high research productivity in recruitments and post replacements,
recognising some appointments will have an emphasis on teaching.
To continue to develop NHS relationship to ensure teaching commitments are
delivered.
18/1/08
3
LTC2007/52.7
o
o
To consider the strategic opportunity resulting from the large number of retrials in
future years.
To appreciate that strategic research appointments often require investment over and
above staff salaries.
Capital Programme
The longer-term capital programme is largely focussed on the essential capital schemes for
the new South Glasgow Hospital and the refurbished Glasgow Royal Infirmary (GRI). The
development of these hospital sites by NHS GGC represents an unprecedented opportunity
for the University. In addition, pressures driving our requirements at these sites include the
stepwise increase in undergraduate medical student numbers from 2010; the closure of
Yorkhill (~2011) and of the Western Infirmary (2013).
o
At GRI the University Tower will be refurbished by NHS GGC (2008-10). The
refurbishment will replace windows, ventilation, lifts and all major plant (£11million
funded by NHS GGC). The conversion of the academic space on Levels 2 and 3 will
need to co-ordinate with the re-occupation of this space, and we will need to fund the
internal refurbishment of this space estimated to cost about £2-£3M.
o
At SGH there is a longer timescale leading up to 2014 for the establishment of an
Academic Medical Centre (GU), partnership on a Clinical Skills & Education Centre
(with other partners) and a new Clinical Research Facility (with NHS GGC).
The planned capital development at Garscube (Beatson Phases 2 & 3) will be funded through
SRIF and the Medical Development Fund.
As mentioned above, we have also submitted plans to enable an MRI scanner to be located
within the BHF GCRC. This scanner is urgently required on the Gilmorehill site and we are
hopeful that the BHF will fund the full cost of the scanner (~£1.5m). The University will be
required to meet the cost of the refurbishment (~£1.2m) to accommodate the scanner, and also
staff costs.
2. Review of recent performance
2.1. Summary of last 2-years financial results
The Faculty of Medicine delivered a surplus of £500K in 06/07 and is forecast to
deliver a surplus of £1M in 07/08. A surplus of £1M is forecast for 08/09. This
compares with recurrent deficits of £2-£3M per annum over the previous 10 years.
A Gross contribution of £13.7M is forecast for 08/09 which is £217K above the 07/08
budget and £184K higher than the 08/09 forecast included in last year’s plan.
18/1/08
4
LTC2007/52.7
2.2. Research Performance
2.2.1 Research Awards 2003 - 07
Total Value of Awards
Millions
FACULTY OF MEDICINE - VALUE OF AWARDS
£14.0
Research Councils
CSO
£12.0
UK Charity
UK Government
£10.0
UK Industry
EU
£8.0
Overseas
Other
£6.0
£4.0
£2.0
£0.0
FY2003
FY2004
FY2005
FY2006
FY2007
Financial Year
The value of awards from Charities has decreased over the period although, as seen below,
applications are increasing. Awards from Research Councils and CSO have increased
recently, as has UK industry.
2.2.2
New research awards with overheads for last year and the first 5 months of this year
have increased from previous years as detailed below:
Financial
Year
FY2007
FY2006
FY2005
FY2004
FY2003
£1,396,696 £437,999 £427,957 £611,602 £104,456
£779,366 £165,585 £555,010 £366,440 £312,735
£35,600
£5,369
£13,286
£0
£18,267
£970,670 £446,101 £230,580 £147,944 £444,261
£756,641 £231,282 £175,169 £310,572 £226,618
£168,127 £115,490
£73,560
£89,716 £194,369
£159,834 £106,719 £217,063 £154,967 £153,972
£50,878
£2,423
£15,112
£33,563
£7,935
£4,317,811 £1,510,967 £1,707,738 £1,714,803 £1,462,612
18/1/08
5
LTC2007/52.7
FY2008 - first 5
FY2007 - first 5
months
months
Research Councils
CSO
UK Charity
UK Government
UK Industry
EU
Overseas
Other
TOTAL
£476,921
£443,031
£16,142
£187,490
£176,187
£0
£42,129
£0
£1,341,900
£715,834
£0
£0
£427,783
£150,819
£3,844
£11,360
£0
£1,309,640
2.2.3. Research Applications 2003 - 07
Millions
FACULTY OF MEDICINE - VALUE OF APPLICATIONS
£50.0
Research Councils
CSO
UK Charity
Total Value of Awards
£40.0
UK Government
UK Industry
EU
£30.0
Overseas
Other
£20.0
£10.0
£0.0
FY2003
FY2004
FY2005
FY2006
FY2007
Financial Year
2.2.4. 2007 Financial Split
FACULTY OF MEDICINE - Funding Sources FY2007
EU
3%
Overseas Other
3%
3%
Research
Councils
18%
UK Industry
14%
CSO
13%
UK Government
13%
UK Charity
33%
18/1/08
6
LTC2007/52.7
2.2.5. Divisional - level Analysis
Total Award Value by Division
Developmental
Medicine
£2,579,706
Nursing
£399,903
Dentistry
£149,981
BHF GCRC
£4,100,039
Cardiovascular &
Medical Sciences
£2,686,680
Community Based
Sciences
£3,443,035
Clinical
Neurosciences
£2,342,875
Immunology
£4,228,530
Cancer
£6,077,982
2.2.5
Staff
BHF GCRC
Cardiovascular and Medical Sciences
Immunology, Infection & Inflammation
Cancer Sciences & Molecular
Pathology
Clinical Neurosciences
Community Based Sciences
Developmental Medicine
Dental School
Total No
90.08
56.04
67.95
Academic
57.08
23.4
50.35
156.29
39.2
109.79
86.68
75.15
105.25
20.9
76.34
54.14
49.15
Research Income FY2007
Total per
Academic
Total
FTE
£4,802,390
£84,134
£1,366,211
£58,385
£2,703,114
£53,686
£4,778,249
£929,342
£2,029,439
£1,862,372
£333,135
2.3. Summary of achievements over last 2 years
Cancer Division
o Succeeded in the key challenge of transferring key Beatson Institute staff to
University contracts so that they could be returned as Cat A staff in the RAE in
order to safeguard £1M+ annual income,
o Research being focused within the new Glasgow Centre for Cancer Research at
Garscube and Gartnavel in new buildings (£162M) that have been completed in
2007/08,
o New Head of Division successfully appointed following unexpected resignation
of previous HoD,
o Forensic & Toxicology contracts worth £19M were awarded (at FEC prices),
o Professor Hing Leung appointed to Chair in Urology & Surgical Oncology.
BHFGCRC
o Successful move into the BHFGCRC,
18/1/08
7
£45,399
£44,466
£26,584
£34,399
£6,778
LTC2007/52.7
o
o
o
3iiis
o
Recruitment of Professor Hübner to BHF Chair (key appointment) prior to
RAE census date.
Seemless collaboration across the biomedical territory with regard to the
RAE return which resulted in 52 Cat A members of staff across three
Faculties being included.
Development of the Glasgow Comprehensive Cardiovascular Centre in close
collaboration with the NHS, designed to produce clinical excellence
seamlessly integrated with basic research and facilities for rapid transfer of
research into new diagnostics, prevention and treatment.
Successful move into the GBRC
Dentistry
o Introduction of a completely revised BDS curriculum,
o SFC agreed to fund the Second Year of the BDS at the clinical TUR.
Developmental Medicine
o Appointed Professor Jane Norman to Regius Chair in O&G, Professor Kinsella to
Chair in Anaesthesia, and Professor Lee to Chair of Molecular Paediatrics.
Community Based Sciences
o Appointed Professor Jill Pell to the Henry Mechan Chair and and Professor Andy
Briggs to the Lindsay Chair.
o New Head of Division successfully appointed.
Clinical Neuroscience
o Appointment of Professor Linington to Chair of Neuroimmunology
Medical Sciences
o Professor Macfarlane is generating new royalty agreements worth 250Kpa,
Nursing
o Highly satisfactory DPTLA Review and successful re-accreditation of UG and
MSc programmes.
Education & Administration
o Significant increase in 2007 KTG return and RAE income returns due to major
efforts in identifying previously ‘hidden’ research within the NHS.
o Highly satisfactory GMC review of undergraduate medical education.
o Successful development of enhanced Research Office and Finance Office.
o Governance of clinical trials reviewed as a priority and significant progress made
in advance of the December MHRA inspection which had a successful outcome.
Benchmark comparisons.
o Biomedicine has increased its position in THES 2007 International League
Tables, from 75th position to 60th .
o Dentistry was rated 2nd in the UK in the Times Online and 3rd in the 2007
National Student Survey
o Nursing was placed 6th in the guardian League Table.
18/1/08
8
LTC2007/52.7
3. SWOT Analysis
Faculty’s Strengths













Faculty’s Weaknesses












External Opportunities
18/1/08


An international profile in key research areas
(particularly
cardiovascular,
cancer
and
inflammation/immunity; and to some extent Public
Health), which will hopefully be recognised in the
RAE2008 results.
Strong inter-disciplinary research across the biomedical
territory (recognised in THES international league
table).
Excellent new research infrastructure on Gilmorehill
campus and Garscube.
Good interaction between basic scientists and academic
clinicians.
Innovative undergraduate teaching programmes
commended by regulatory bodies.
Excellent relationships and joint planning with NHS
GGC – this is a key strength as most institutions in the
sector have not succeeded in this yet.
Strong representation on UK and Scottish policy
making bodies
Partnerships with other Faculties and institutions
A large patient population base for teaching and
research – GGC covers >50% of the Scottish population
Excellent teaching infrastructure for undergraduate
medicine (years 1 & 2)
Significant increase in staff morale and enthusiasm over
last year.
Faculty administration and financial management.
Strategic ambition of key staff
Failure to grow research income (and research
contribution) as quickly as planned
Clinical imaging facilities for research on Gilmorehill
site and lack of academic expertise in clinical imaging
Low Wyeth / TMRI success
PhD student numbers should be higher
Multiple clinical sites and poor transport links
Biomedical faculties’ strategies not aligned
Poor quality or inadequate accommodation on many
clinical sites
Planning for new hospital sites
Neuroscience not aligned across the territory, although
strengths in some areas.
Nursing weak – but politically important
Identification of some clinical staff with their clinical
site rather than the Faculty
Substantial number of senior retirals in the next 10
years / succession planning
Wyeth / TMRI
Joint planning of clinical site facilities at new SGH and
9
LTC2007/52.7








External Threats












GRI with NHS
Glasgow Biomedicine / clinical trials
Availability of accommodation/land as WIG and
Pharmacy vacated.
Relationship with Beatson Institute / GCCR
SCREDS
Increasing collaboration with other Scottish Medical
Schools
Additional SFC and ACT funding from St Andrews
students
National patient database / patient population is unique
selling point
Aligning components of public health would create
opportunities
Gap between Edinburgh and Glasgow is widening, and
noticeably affecting our ability to win research funding.
The gap will continue to widen without investment.
MHRA inspection / need to invest in clinical
governance to ensure competitiveness
Lack of top up fees
SFC Funding settlement
Retention of key staff / poaching from competitor
institutions / low morale during hospital re-organisation
Changes in NHS plans
Unattractiveness of clinical academic career to most
young clinicians
Implementation of Cooksey
Pressure of clinical targets on research and teaching
Challenges of revalidation for clinical staff
New IT and records system – integration with VALE
Pressure on NHS training budgets e.g. for Clinical
Psychology
4. Faculty Strategic Objectives
1. To have a detailed plan in place in response to the strategic realignment of the
two major Glasgow hospitals, that will enhance our research capabilities, deliver
the clinical teaching for the expansion in UG Medical Students and PGT courses,
and house staff who have to relocate as a result of the closure of the Western and
Yorkhill hospital sites.
GRI
Refurbishment of University space in the QEB building is estimated at £2-3M and
will need to commence in 2008/09. The refurbished area will contain staff
accommodation, near patient research laboratory facilities, a Clinical Research
Facility and an Education Centre.
SGH
Significant capital schemes will need to be developed for completion by 2013/14 to
accommodate 3 projects of importance to Medicine in Glasgow.
18/1/08
10
LTC2007/52.7



A major academic medical centre to house clinical academic staff and
existing /planned PGT programmes. This will be an exclusively UoG
development.
A Clinical Skills & Education Centre (potentially completed before 2013).
This is a multi user development and will be developed in partnership with
NES, RCPSG, NHSGGC, & Glasgow Caledonian University. The University
will not be the capital lead in this project.
Clinical Research Facility – funding still to be identified.
2. To continue to capitalise on our investments in our priority research areas of
cardiovascular, cancer, and infection, immunity & inflammation, by delivering
world-class research that translates into clinical benefits. However, we recognise
that our competitor institutions are investing heavily and we therefore need to do
likewise in order to remain internationally competitive, attract key staff and secure
major funding. In particular, we would like the ability to invest further in the areas of
cardiovascular and immunology & inflammation (~£250k per area). It is particularly
difficult to recruit research stars in these areas, and therefore no new posts have been
included in the budget. However it is essential that we have the ability to react to
opportunities should they arise;
3. Moving forward from RAE2008, to ensure that we are well-placed for our
international excellence to be recognised in future metrics-based assessments, to
obtain the best research profile and the best financial return for the University. As a
priority, we require to focus our investment in key areas of strength in order to be
internationally competitive, but we will also consider other approaches e.g. publication
strategy, mechanisms to increase MRC income etc. ;
4. To continue to strengthen and consolidate our strengths in other research areas, in
particular clinical and basic neuroscience, and public health. In particular, we wish to
consolidate neuroscience researchers within the West Medical Building as part of the
neuroscience coalescence strategy led by Professor Willison, and also to consider colocating different aspects of public health when suitable accommodation is identified;
5. To strive to achieve a balanced research portfolio in funding terms in order to achieve
an increasingly higher proportion of full economic costs and to ensure research
sustainability. A separate plan is being developed regarding research management (see
appendix), which includes a request to recruit a Business Development Manager to work
within the Faculty to specifically focus on increasing research funding from sources that
will at least meet FEC.;
6. To increase our undergraduate student numbers in medicine (through our successful
bid for St Andrews students for their clinical training, following the Calman Report),
Nursing and Dentistry;
7. To increase our postgraduate student numbers, and particularly international
postgraduate student numbers, through our new and expanded MSc taught courses
and also by attracting the most able graduate research students;
5. Risk analysis
Objective
Refurbishment of
18/1/08
Risk
o
Funding not being
Impact
H
11
Prob
M
Mitigating action
LTC2007/52.7
University space
in the QEB
building
SGH capital
developments
achieved
o
o
o
Maintain
international
excellence in
research
o
o
o
o
o
Balanced
research
portfolio
/research
sustainability
o
Increase
UG
student numbers
o
o
Growth
research
contribution
18/1/08
H
H
Need early, effective planning
and fundraising strategy
Serious
competition from
other HEIs
Inability to respond
quickly
to
opportunities
SFC settlement not
in
line
with
expectations
MHRA inspection
Funding
not
achieved
for
Cancer
Translational
Research Centre
Financial effect of
Beatson MoU not
fully known
H
H
Must have financial flexibility to
be able to respond quickly to
opportunities and threats
Do not succeed in
increasing
research
contribution
H
Must be able to invest in clinical
governance requirements to
ensure compliance.
University must resource new
Clinical Trials Office.
Develop strong relationship
with Beatson Institute
M
Need strategy for increasing
income from FEC sources, such
as TMRI.
Need to invest in
research support office
o
Increase
overseas
numbers
Funding not being
achieved
Lack
of
accommodation for
staff transferring
from Yorkhill and
Western
in
PG
o
in
o
Paucity of suitable
lecture theatres to
accommodate
whole class when
St A’s students
arrive
Poor condition of
Dental Hospital
building
Proposed Aberdeen
Dental School
Recruitment of
overseas PG
numbers is less
than forecast
Growth in research
contribution is not
delivered
strong
M
M
H
M
See appendix on iniatitives to
increase PG numbers
H
M
See appendix on iniatitives to
grow research contribution.
12
LTC2007/52.7
Key Performance Indicators table – see attached
Income & Expenditure accounts – see attached.
Capital Projects
07/08
o
o
o
o
Completion of Beatson Institute at Garscube,
Completion of Leukaemia building at Gartnavel,
Clinical Research Facilities in Tennant building and GRI/QEB,
Refurbishment of Dental School lecture theatres.
08/09
o MRI installation in the basement of the BHFGCRC, - this must be completed in
2008!
o Refurbishment of Beatson buildings and new Translational Research building at
Garscube
o Refurbishment of QEB building at GRI
o Relocation of Biomedicine neuroscientists into the West Medical School
building.
2012/14
o SGH Education & Skills Centre,
o SGH Academic Medical centre
o SGH CRF
Other potential projects
o Dental School & Hospital refurbishment
o Relocation of Public Health(inc MRC Unit) in the Beatson Building on the
Western site
o Relocation of Psychological Medicine
o Purchase of pharmacy building (available 2011) and relocate small bore MRI.
In addition, at a territorial level there is an imperative to demonstrate commitment to
Virology across the Biomedical Territory for the goal of retaining the MRC Virology
Unit and building a virology strength in the Vet and IBLS Faculties. This involves
planned development at Garscube but a Medical Faculty presence in virology is
necessary for this strategic territorial initiative to be successful.
o
New 320 lecture theatre at Gilmorehill would be a major advantage if developed
centrally.
18/1/08
13
LTC2007/52.7
Planning & Budgeting – 08/09
Faculty of Medicine
Appendix 1 – Development of Research Management
This appendix describes some of the measures that are being put in place or proposed
to address the following two key Faculty objectives:

To strive to achieve a balanced research portfolio in funding terms in order to achieve an
increasingly higher proportion of full economic costs and to ensure research sustainability;

Moving forward from RAE2008, to ensure that we are well-placed for our international
excellence to be recognised in future metrics-based assessments, to obtain the best research
profile and the best financial return for the University;
1. Strengthening the Faculty Research Office
During the run-up to the RAE we employed a temporary administrator to support our
Research Administrator who was heavily involved in the RAE. This support has also
allowed us to develop additional processes for research management, including
Award PAFs and detailed management information at a Divisional level. It has also
allowed us to develop a web page for the Research Office
(http://www.gla.ac.uk/faculties/medicine/researchoffice/) which includes advice for
researchers and details of relevant funding opportunities. We have now budgeted to
maintain this additional support, and further develop the research office as a valuable
resource for both researchers and management. During early 2008 we will expand
our management information to include benchmarking with competitor institutions
and detailed analysis of funding at an individual level to allow us to target funding
opportunities and tailor support to staff.
2. Mentoring / training for research staff
The Faculty’s Research Strategy Committee has developed a strategy to encourage
and support applications to the MRC. Making use of staff who sit on MRC panels, it
has been agreed that all applications to the MRC will be developed in conjunction
with experienced staff and reviewed internally before submission. It is hoped that this
will allow us to increase our success rate to the MRC and encourage younger
researchers to develop applications. In addition, it is possible that Research Council
income will be used as a metric post-RAE 2008 and it is therefore important for us to
increase our MRC income as much as possible.
3. Faculty support for Business Development
Although income from UK industry has increased slightly from 2006, overseas
income has fallen and the Faculty is still heavily reliant on charity income (see
below).
18/1/08
14
LTC2007/52.7
FACULTY OF MEDICINE - Funding Sources FY2007
EU
3%
Overseas Other
3%
3%
Research
Councils
18%
UK Industry
14%
CSO
13%
UK Government
13%
UK Charity
33%
In addition, we are aware that Glasgow has not been as successful as other Scottish
institutions in securing funding from the TMRC / Wyeth collaboration. We therefore
propose to recruit an experienced Business Development Manager, whose objective
will be to increase research funding from sources that will meet or exceed FEC. This
post should quickly become self-financing but will be funded initially from KTG
income. We envisage that the post-holder will have a biomedical background and
substantial business development experience. Their activities will be aligned to
Faculty priority areas, although they will also be encouraged to develop cross-Faculty
and interdisciplinary activity. Note that this post has not been included in the attached
I&E, but the Faculty would like permission to move forward with this approach after
discussion with the Vice-Principal (Research & Enterprise). (In addition we be appointing
a clinical academic lead for all Wyeth projects, who will have responsibility for developing
the relationship with Wyeth, overseen by the Associate Dean for Research.)
4. Increasing external profile
Although the Faculty’s external profile is largely determined by its academic staff and
their publications, we intend to support this by developing the Faculty’s research web
pages and by developing a brochure and DVD to promote our research strengths to a
variety of audiences.
5. Development of Glasgow Biomedicine
Having secured a favourable outcome from the recent MHRA inspection, the area of
clinical trials represents an opportunity for growth in partnership with NHS Greater
Glasgow & Clyde. Developments this year will include the opening of a new joint
Clinical Trials Office that will operate as a one-stop shop for researchers. We will aim
to promote Glasgow Biomedicine and our proposed Business Development Manager
will also have a role in increasing income from commercial clinical trials. In addition,
we will be reviewing the distribution model with NHS GG&C.
18/1/08
15
LTC2007/52.7
Planning & Budgeting – 08/09
Faculty of Medicine
Appendix 2 – Faculty of Medicine Graduate School
Use of Budget Allocation for 2007/08 to Increase International Student Numbers
Part Scholarships
Part Scholarships are offered by the Faculty of Medicine to international students (nonEU) for admission by the University of Glasgow as full-time, postgraduate research or
postgraduate taught students for the 2008-09 academic session. Part Scholarships are also
available to postgraduate research students classified as Home/EU, although postgraduate
taught Home/EU students are not eligible to apply.
The Part Scholarship covers the cost of the Home/EU fee and for international students,
the Faculty of Medicine will pay the Home/EU fee equivalent, leading to a discount of
around £3,240.
New awards are granted annually, on a competitive basis, to international postgraduate
students and home/EU postgraduate research students of outstanding academic ability.
It is anticipated that 30 part scholarships will be offered for session 2008/09,
amounting to approximately £98,000. 10 part scholarships will be offered to
Postgraduate Research students and the remaining 20 part scholarships will be offered to
students undertaking a Postgraduate Taught Degree.
Electronic Forum
As part of the Graduate School’s bid to increase international student numbers, it is
envisaged that an electronic forum will help foster relations with students from around the
world. The electronic forum will be developed as part of the Graduate School web site,
and will allow international students to post messages to current students within the
university, members of staff, overseas collaborators, and key alumni. This will allow
prospective international students to get a ‘feel’ of the university and to answer any
important questions. The electronic forum will also allow prospective students to feel as
though they are part of a welcoming, academic community, and in turn, this should
translate into increased student numbers.
Development of the electronic forum is anticipated to take approximately 3 – 6
months, and would require full-time commitment from a member of staff in IT to
develop this facility.
Promotional Materials
Members of staff from the International and Postgraduate Service have kindly offered to
take along promotional material from the Faculty of Medicine Graduate School when
attending any international events or conferences. It is anticipated that the Graduate
School will produce a prospectus outlining each of the programmes on offer. As the web
site will be the communication medium most widely used for attracting prospective
students, it is likely that only 1000 prospectuses will be produced, amounting to
around £1500.
18/1/08
16
LTC2007/52.7
Overseas Ambassadors
The International & Postgraduate Service are eager to have Faculty academic staff
accompany their staff on visits overseas or, alternatively, will provide promotional
materials for those who may be able to extend their travel abroad to incorporate
recruitment activity. It is thought that £10,000 should be allocated to support academic
staff in participating in overseas recruitment ventures.
Advertising Budget
The advertising budget for 2007/08 has been increased to £10,000 for academic session
2007/08, which will be used for advertising on FindaPhD.com and FindaMasters.com, in
addition to funding advertisements in New Scientist and Nature. Studentships for
2008/09 have already been advertised on FindaPhD.com, together with an additional
advertisement on the home page of the site. This has led to a large increase in the number
of applications received although exact figures will not be available until after the closing
date on 14th December 2007. The next Graduate School Recruitment Day is scheduled to
take place on 5th March 2008, and advertisements for this event will be placed in New
Scientist, Nature and on FindaPhd/FindaMasters.com.
International Partnership Development Funds
We wish to promote the development of high quality joint degree programmes in
collaboration with partner institutions internationally. £10,000 has been allocated from
the Corporate Investment Fund for the academic session 2007/08 to pump-prime the
development of joint programmes.
Overseas PGR students – income returned to PI/Supervisor
From academic session 2007/08 onwards, 25% of the fee income generated from overseas
Postgraduate Research students will be returned to the PI/Supervisor. It is hoped that this
will lead to an increased willingness from PIs/supervisors/PG conveners to attract and
retain overseas students to their research programmes. While relative growth in
international PGR recruitment is achievable, this will be limited by supervision capacity
and it is hoped that these extra funds will help to ease pressure on supervisors.
18/1/08
17